Comment on: the influence of the pharmaceutical industry on the off-label use of its medicines
Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or …
| Autor principal: | |
|---|---|
| Tipo de documento: | Recurso Electrónico Artigo |
| Idioma: | Inglês |
| Verificar disponibilidade: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Publicado em: |
2002
|
| Em: |
Journal of medical ethics
Ano: 2002, Volume: 28, Número: 4, Páginas: 277 |
| Acesso em linha: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |
| Resumo: | Gebhardt draws attention to an important issue. The responsibility for informing and warning patients about adverse effects and how to prevent them, or … |
|---|---|
| ISSN: | 1473-4257 |
| Obras secundárias: | Enthalten in: Journal of medical ethics
|
| Persistent identifiers: | DOI: 10.1136/jme.28.4.277-a |
